Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. NVAX
    4. >
  4. Valuation

Valuation

-
stocks logo
NVAX
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is NVAX Overvalued？

NVAX is now in the zone, suggesting that NVAX current forward PE ratio of -10.42 is considered compare with the five-year average of 1.15.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

NVAX Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
NVAX.O
Novavax Inc
loss
Average P/E: 26.82
40.06%
1.49B
stocks logo
KMDA.O
Kamada Ltd
26.82
Average P/E: 26.82
24.82%
398.13M
stocks logo
VIR.O
Vir Biotechnology Inc
loss
Average P/E: 26.82
-28.52%
1.42B
stocks logo
GLPG.O
Galapagos NV
loss
Average P/E: 26.82
-211.65%
1.55B
stocks logo
MRVI.O
Maravai LifeSciences Holdings Inc
loss
Average P/E: 26.82
-1328.42%
1.42B
stocks logo
DYN.O
Dyne Therapeutics Inc
loss
Average P/E: 26.82
2.28%
1.39B

NVAX Revenue Breakdown & PS Ratio Relation

By Business
By Region
Currency:USD
Composition ()
Name
Revenue
Percentage

NVAX FAQs

Is NVAX currently overvalued based on its P/E ratio?

According to the provided data, NVAX's 5-year historical average forward P/E ratio is 1.15. NVAX forward P/E ratio is -10.42, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for NVAX?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has NVAX's Price to Sales (PS) ratio evolved?

The PS ratio increased from 1.71 to 2.10, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for NVAX's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

NVAX PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
1.15
Current PE
-10.42
Overvalued PE
24.07
Undervalued PE
-21.77

NVAX EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-13.52
Current EV
8.21
Overvalued EV
48.36
Undervalued EV
-75.40

NVAX P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
2.32
Current PS
3.73
Overvalued PS
4.50
Undervalued PS
0.14

NVAX Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
NVAX.O
Novavax Inc
loss
Average P/E: 26.82
40.06%
1.49B
stocks logo
KMDA.O
Kamada Ltd
26.82
Average P/E: 26.82
24.82%
398.13M
stocks logo
VIR.O
Vir Biotechnology Inc
loss
Average P/E: 26.82
-28.52%
1.42B
stocks logo
GLPG.O
Galapagos NV
loss
Average P/E: 26.82
-211.65%
1.55B
stocks logo
MRVI.O
Maravai LifeSciences Holdings Inc
loss
Average P/E: 26.82
-1328.42%
1.42B
stocks logo
DYN.O
Dyne Therapeutics Inc
loss
Average P/E: 26.82
2.28%
1.39B

NVAX Revenue Breakdown & PS Ratio Relation

By Business
By Region
Currency:USD
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is NVAX undervalued？Is NVAX overvalued compared to its competitors？

NVAX FAQs

Is NVAX currently overvalued based on its P/E ratio?

According to the provided data, NVAX's 5-year historical average forward P/E ratio is 1.15. NVAX forward P/E ratio is -10.42, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for NVAX?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has NVAX's Price to Sales (PS) ratio evolved?

The PS ratio increased from 1.71 to 2.10, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for NVAX's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is NVAX undervalued？Is NVAX overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free